Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis

Junichiro Mizuguchi¹, Masaru Takeuchi, Masahiko Usui

¹Department of Immunology, Tokyo Medical University, Japan. mizu@tokyo-med.ac.jp

Archivum Immunologiae Et Therapiae Experimentalis

|October 10, 2002

Summary

Type I interferons (IFN-alpha/beta) show therapeutic potential in autoimmune diseases like uveitis. Their beneficial effects depend on the specific immune response context and cytokine balance.

Area of Science:

Immunology
Autoimmune Diseases
Ophthalmology

Background:

Type I interferons (IFN-alpha/beta) show promise in organ-specific autoimmune diseases.
T helper 1 (Th1) cell responses drive autoimmune uveitis, while T helper 2 (Th2) responses are protective.
Experimental autoimmune uveoretinitis (EAU) is a model for human uveitis pathogenesis.

Purpose of the Study:

To investigate the immunomodulatory mechanisms of Type I interferons (IFN-alpha/beta) in autoimmune uveitis.
To explore the role of cytokine milieu and T helper cell responses in IFN-alpha/beta's therapeutic effects.

Main Methods:

Utilized the experimental autoimmune uveoretinitis (EAU) animal model.
Analyzed the impact of IFN-alpha/beta administration on disease development.
Assessed changes in cytokine production (IFN-gamma, IL-4, IL-10) and T helper cell phenotypes.

Main Results:

IFN-alpha/beta administration prevented EAU development.
This prevention was associated with reduced production of IFN-gamma and IL-10.
IFN-alpha/beta demonstrated beneficial effects in both Th1 and Th2-like disease phenotypes.

Conclusions:

IFN-alpha/beta exhibit potent immunomodulatory effects in autoimmune uveitis.
The efficacy of IFN-alpha/beta is context-dependent, influenced by cytokine combinations and concentrations.
Further research into IFN-alpha/beta's precise mechanisms could lead to novel therapeutic strategies for autoimmune diseases.

Related Experiment Videos

Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis

Related Concept Videos

Systemic bias in medical consensus: how flawed panels and lack of evidence can distort definitions and guidelines: the case of Vogt-Koyanagi-Harada disease : Perspective.

Non-Infectious Choroiditis Subdivided into Its Diverse Pathophysiological Sub-Groups Is the Best-Known and Most Appropriate Nomenclature to Date for the Reclassification and Diagnosis of Former White Dot Entities.

Immunological Profiling of Leukocyte Subset Proportions and Novel Blood Biomarkers in the Acute Phase of Ocular Sarcoidosis and Vogt-Koyanagi-Harada Disease: An Exploratory Pilot Study.

Efficacy of ripasudil-brimonidine fixed-dose combination in secondary glaucoma associated with uveitis: a retrospective study.

Age-Related Differences in the Etiology and Clinical Characteristics of Uveitis in Japan: A Retrospective Comparative Study.

Opposing pathophysiological concepts in multiple evanescent white dot syndrome: The great MEWDS schism.

Isovitexin can Alleviate Fracture-Related Infection, Promote Osteogenesis, and Inhibit Activation of the NF-κB Signaling Pathway.

Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells.

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity.

sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis.

Saccharomyces cerevisiae β-Glucan Training Induces a Nonclassical PGE2-High/NO-Low Macrophage Phenotype in Response to Pseudomonas aeruginosa Exopolysaccharide.

Integrated peripheral immune profiling reveals B-cell dysregulation and CD8 effector signatures in chronic inflammatory demyelinating polyneuropathy.

An iguratimod prodrug reduces RA-FLS invasiveness by disrupting STAT1-C3-TNFα-mediated crosstalk between fibroblast-like synoviocytes and macrophages.

Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry.

Primary adrenal epithelioid angiosarcoma: An extraordinarily rare malignancy with a challenging diagnosis.

Nodal metastasis from an occult duodenal gastrinoma amid an overlap of xanthogranulomatous and type 1 autoimmune pancreatitis: A case report.

Utility of monocyte-derived cells to investigate immune-mediated drug-induced liver injury.

Related Experiment Videos

Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles